Loss of allograft inflammatory factor-1 ameliorates experimental autoimmune encephalomyelitis by limiting encephalitogenic CD4 T-cell expansion

Keyphrases

• Experimental Autoimmune Encephalomyelitis 100%
• CD4 T Cells 100%
• AIF1 100%
• Multiple Sclerosis 60%
• Central Nervous System 60%
• Demyelination 40%
• MOG35-55 40%
• Gene-deficient Mice 20%
• Inflammatory Cytokines 20%
• Spinal Cord 20%
• Inflammation 20%
• Microglia 20%
• Autoreactive T Cells 20%
• Leukocytes 20%
• Myelin 20%
• Putative Drug Targets 20%
• Immunization 20%
• Cytokine Milieu 20%
• Activated Microglia 20%
• Leukocyte Infiltration 20%
• Ca2+ Binding 20%
• Adapter 20%
• Peripheral Blood Cells 20%
• Activated Macrophages 20%
• Myelin Oligodendrocyte Glycoprotein 20%
• Autoreactive 20%
• Traf Ficking 20%
• Potent Molecules 20%
• CD8 T Cells 20%
• Positive Contributions 20%
• First Assessment 20%
• Inflammatory Cytokine Expression 20%

Immunology and Microbiology

• Cell Expansion 100%
• T-Helper Cell 100%
• Experimental Autoimmune Encephalomyelitis 100%
• Allograft Inflammatory Factor 1 100%
• Central Nervous System 60%
• Multiple Sclerosis 60%
• Proinflammatory Cytokine 40%
• Microglia 40%
• Leukocyte 40%
• Macrophage 20%
• Cytotoxic T-Cell 20%
• Spinal Cord 20%
• T Cell 20%
• Myelin 20%
• Cell Activation 20%
• Myelin Oligodendrocyte Glycoprotein 20%
• Peptides 20%
• Inflammation 20%
• Therapeutic Target 20%

Neuroscience

• T Cell 100%
• CD4 100%
• Experimental Autoimmune Encephalomyelitis 100%
• Cell Expansion 100%
• AIF1 100%
• Central Nervous System 50%
• Multiple Sclerosis 50%
• Microglia 33%
• Proinflammatory Cytokine 33%
• Leukocyte 33%
• Macrophage 16%
• Myelin 16%
• CD8 16%
• Cell Activation 16%
• Myelin Oligodendrocyte Glycoprotein 16%
• Peptide 16%
• Spinal Cord 16%